Thiomersal: implementation of the warning statement relating to sensitisation - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document provides guidance on the wording of the summary of product characterisitics and the package leaflet for the use of thiomersal in medicinal products with regard to sensitisation.
A 2016 review of this guideline concluded that it remains up-to-date and relevant.
Keywords: Thiomersal, preservative, vaccines, immunoglobulins, antimicrobial, organomercuric, summary of product characteristics (SmPC), sensitisation